• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Smartphone Mental Health Apps Can Help Reduce Symptoms Of Anxiety And Depression

byUsamah BhaiduandFlaviu Trifoi
January 30, 2024
in Psychiatry, Wellness
Reading Time: 2 mins read
2 Minute Medicine Rewind October 21, 2019
Share on FacebookShare on Twitter

1. Smartphone mental health apps have a small but significant effect on reduction of general anxiety and depressive symptoms.

2. Mental health apps which incorporate cognitive behavioral therapy, or chatbot features have the greatest impact on symptom reduction.

Evidence Rating Level: 1 (Excellent)

Treatment of mental health disorders is being revolutionized by technological innovation. Smartphone apps geared towards mental health have become a very popular tool for managing mental health symptoms. With an overburdened healthcare system, access to mental health care has become increasingly difficult in recent years. Smartphone apps can be a cost effective, quick tool that individuals can access at their own convenience. Previous research has shown strong support for the efficacy of smartphone apps to manage symptoms of depression and general anxiety. However, precise and powerful analysis on the effects of mental health management by smartphone apps has been limited by a lack of studies.

This meta-analysis included studies published up until June 2023 which looked at the impact of smartphone apps on managing symptoms of general anxiety and depression. 176 randomized control trials from 174 papers which compared smartphone apps to controls (placebo, face-to-face treatment, waitlist) on managing symptoms of anxiety and depression were included in the meta-analysis. Studies which blended app and web-based interventions, apps which did not have mental health as a sole focus (ie. diet apps), text messaging, and studies which incorporated apps with face-to-face therapy were excluded. The smartphone apps used in the studies incorporated mood tracking, cognitive behavioral therapy (CBT), or chatbot features. The primary outcome measure was the reduction of general anxiety or depressive symptoms.

Compared to control groups, smartphone apps caused a small but significant reduction of general anxiety or depressive symptoms. Reduction of general anxiety symptoms was most profound when apps were primarily geared towards general anxiety, and incorporated CBT into management. Reduction of depressive symptoms was most significant when apps used CBT, or chatbot features. These effects persisted upon follow-up which took place 1-4, or 5-12 weeks post initial assessment. A limitation of this study is the heterogeneity in the samples studied in terms of severity of symptoms, and the quality of apps used. Nevertheless, to date this is the most comprehensive study to investigate the efficacy of smartphone apps on the management of mental health symptoms. Smartphone apps are a worthwhile adjunct to conventional treatment clinicians may consider incorporating into management of general anxiety and depression.

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Behavioral support does not improve patient-directed opioid tapering success

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Click here to read this study in World Psychiatry

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietyappCBTdepressionsmartphone
Previous Post

Cemiplimab for Kidney Transplant Recipients With Cutaneous Squamous Cell Carcinoma

Next Post

#VisualAbstract: Ubrogepant is safe and effective for acute treatment of migraine prodrome

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Next Post
#VisualAbstract: Ubrogepant is safe and effective for acute treatment of migraine prodrome

#VisualAbstract: Ubrogepant is safe and effective for acute treatment of migraine prodrome

Rivaroxaban after TAVR linked with increased risk of adverse events compared to antiplatelet therapy

Non-invasive ultrasound therapy safely improves aortic valve function in high-risk patients with calcified aortic stenosis

#VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

#VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.